18838678Zhang Z, Zhang Y, Ning G, Deb DK, Kong J, Li YCProceedings of the National Academy of Sciences of the United States of AmericaAngiotensin II Type 1 Receptor Blockers; Diabetic Nephropathies; Renin; Vitamin DAnimals; Diabetes Mellitus, Experimental; Drug Combinations; Ergocalciferols; Losartan; Mice; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; StreptozocinCombination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase. Proc Natl Acad Sci U S A. 2008 Oct 14; 105(41):15896-901.Proc Natl Acad Sci U S A2008-10-06T00:00:002008Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areaInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000818Living Beings1457265180.249624AnimalsD003921Disorders611900.900961Diabetes Mellitus, ExperimentalD003928Disorders442480.803575Diabetic NephropathiesD004872Chemicals & Drugs12380.969079ErgocalciferolsD004338Chemicals & Drugs1322220.941505Drug CombinationsAuthorship 3624860.3421180.3421181authors10.2513has subject areaD044140Chemicals & Drugs18210.993267Receptor, Angiotensin, Type 1D047228Chemicals & Drugs29900.931367Angiotensin II Type 1 Receptor BlockersD051379Living Beings980113130.368397MiceD012084Anatomy371330.90386Renin-Angiotensin SystemD012083Chemicals & Drugs31780.964214ReninD013311Chemicals & Drugs29540.984943StreptozocinD014807Chemicals & Drugs1092610.820216Vitamin DD019808Chemicals & Drugs19420.975741LosartanUniversity of ChicagoYanLiYan Li41.78927490000000-87.601250000000002065Li, Yantrue1